OKYO Pharma Limited (OKYO)
$1.42+2.16%Close
BUYRECOVERY · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $54M
- Beta
- 0.04
- P/E (TTM)
- -6.11
- Short % float
- 0.17%
- Days to cover
- 1.0
- SI change
- -17.8%
- 1W
- -3.40%
- 1M
- -0.70%
- vs SPY 1W
- -4.56%
- vs SPY 1M
- -3.69%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on OKYO?
- LOPJLB’s latest quantitative signal on OKYO Pharma Limited (OKYO) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is OKYO in?
- OKYO Pharma Limited (OKYO) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does OKYO Pharma Limited (OKYO) do?
- OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye conditions and ocular discomfort. Its primary therapeutic candidate is OK-101, specifically designed to address dry eye disease. Additionally, the company is advancing OK-201, an experimental bovine …